1. Home
  2. LANV vs FBLG Comparison

LANV vs FBLG Comparison

Compare LANV & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LANV
  • FBLG
  • Stock Information
  • Founded
  • LANV 2015
  • FBLG 2021
  • Country
  • LANV China
  • FBLG United States
  • Employees
  • LANV N/A
  • FBLG N/A
  • Industry
  • LANV Blank Checks
  • FBLG
  • Sector
  • LANV Finance
  • FBLG
  • Exchange
  • LANV Nasdaq
  • FBLG NYSE
  • Market Cap
  • LANV 196.8M
  • FBLG 163.3M
  • IPO Year
  • LANV N/A
  • FBLG 2024
  • Fundamental
  • Price
  • LANV $1.74
  • FBLG $2.94
  • Analyst Decision
  • LANV
  • FBLG Strong Buy
  • Analyst Count
  • LANV 0
  • FBLG 1
  • Target Price
  • LANV N/A
  • FBLG $16.00
  • AVG Volume (30 Days)
  • LANV 92.4K
  • FBLG 772.5K
  • Earning Date
  • LANV 08-26-2024
  • FBLG 11-02-2024
  • Dividend Yield
  • LANV N/A
  • FBLG N/A
  • EPS Growth
  • LANV N/A
  • FBLG N/A
  • EPS
  • LANV N/A
  • FBLG N/A
  • Revenue
  • LANV $409,961,427.00
  • FBLG N/A
  • Revenue This Year
  • LANV N/A
  • FBLG N/A
  • Revenue Next Year
  • LANV $76.77
  • FBLG N/A
  • P/E Ratio
  • LANV N/A
  • FBLG N/A
  • Revenue Growth
  • LANV N/A
  • FBLG N/A
  • 52 Week Low
  • LANV $0.91
  • FBLG $1.08
  • 52 Week High
  • LANV $4.70
  • FBLG $46.00
  • Technical
  • Relative Strength Index (RSI)
  • LANV 54.79
  • FBLG N/A
  • Support Level
  • LANV $1.60
  • FBLG N/A
  • Resistance Level
  • LANV $1.85
  • FBLG N/A
  • Average True Range (ATR)
  • LANV 0.19
  • FBLG 0.00
  • MACD
  • LANV -0.00
  • FBLG 0.00
  • Stochastic Oscillator
  • LANV 35.35
  • FBLG 0.00

About LANV Lanvin Group Holdings Limited

Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.

About FBLG FIBROBIOLOGICS INC

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Share on Social Networks: